Trials / Completed
CompletedNCT00275912
Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures
A 24-week Prospective Open-label Multicenter Study to Evaluate the Effect on Seizure Frequency, Safety and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 6 Months – 17 Years
- Healthy volunteers
- —
Summary
This study is aimed to collect additional data regarding the efficacy in reducing the frequency of partial seizures, as well as the safety and tolerability, of oxcarbazepine monotherapy in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxcarbazepine |
Timeline
- Start date
- 2006-09-11
- Primary completion
- 2007-09-28
- Completion
- 2007-09-28
- First posted
- 2006-01-12
- Last updated
- 2017-02-23
Locations
5 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT00275912. Inclusion in this directory is not an endorsement.